111 related articles for article (PubMed ID: 9864033)
41. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C.
Wali M; Harrison RF; Gow PJ; Mutimer D
Gut; 2002 Aug; 51(2):248-52. PubMed ID: 12117889
[TBL] [Abstract][Full Text] [Related]
42. HLA class II favors clearance of HCV infection and progression of the chronic liver damage.
Mangia A; Gentile R; Cascavilla I; Margaglione M; Villani MR; Stella F; Modola G; Agostiano V; Gaudiano C; Andriulli A
J Hepatol; 1999 Jun; 30(6):984-9. PubMed ID: 10406174
[TBL] [Abstract][Full Text] [Related]
43. HLA serological and class II genotyping in sarcoidosis patients in Japan.
Ishihara M; Ishida T; Inoko H; Ando H; Naruse T; Nose Y; Ohno S
Jpn J Ophthalmol; 1996; 40(1):86-94. PubMed ID: 8739505
[TBL] [Abstract][Full Text] [Related]
44. HLA class II alleles in Romanian patients with chronic hepatitis C.
Gheorghe L; Rugină S; Dumitru IM; Franciuc I; Martinescu A; Balaş I
Germs; 2015 Jun; 5(2):44-9. PubMed ID: 26097834
[TBL] [Abstract][Full Text] [Related]
45. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation.
Mañez R; White LT; Linden P; Kusne S; Martin M; Kramer D; Demetris AJ; Van Thiel DH; Starzl TE; Duquesnoy RJ
Transplantation; 1993 May; 55(5):1067-71. PubMed ID: 8388584
[TBL] [Abstract][Full Text] [Related]
46. Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population.
Fanning LJ; Levis J; Kenny-Walsh E; Wynne F; Whelton M; Shanahan F
Hepatology; 2000 Jun; 31(6):1334-7. PubMed ID: 10827160
[TBL] [Abstract][Full Text] [Related]
47. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection.
Alric L; Fort M; Izopet J; Vinel JP; Charlet JP; Selves J; Puel J; Pascal JP; Duffaut M; Abbal M
Gastroenterology; 1997 Nov; 113(5):1675-81. PubMed ID: 9352872
[TBL] [Abstract][Full Text] [Related]
48. The Importance of New Generation Sequencing (NGS) HLA Typing in Renal Transplantation-Preliminary Report.
Kotowski M; Bogacz A; Bartkowiak-Wieczorek J; Bukowska A; Surowiec N; Dziewanowski K; Czerny B; Grześkowiak E; Ostrowski M; Machaliński B; Sieńko J
Transplant Proc; 2018; 50(6):1605-1615. PubMed ID: 29937294
[TBL] [Abstract][Full Text] [Related]
49. Association of HLA alleles with response (especially biochemical response) to interferon therapy in Japanese patients with chronic hepatitis C.
Nishiguchi S; Kaneshiro S; Tanaka M; Enomoto M; Akihiro T; Habu D; Takeda T; Fujino K; Tanaka T; Yano Y; Shiomi S
J Interferon Cytokine Res; 2003 Mar; 23(3):135-41. PubMed ID: 12716485
[TBL] [Abstract][Full Text] [Related]
50. HLA class II alleles in Japanese patients with inflammatory bowel disease.
Yoshitake S; Kimura A; Okada M; Yao T; Sasazuki T
Tissue Antigens; 1999 Apr; 53(4 Pt 1):350-8. PubMed ID: 10323339
[TBL] [Abstract][Full Text] [Related]
51. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
[TBL] [Abstract][Full Text] [Related]
52. Long-term outcome of hepatitis C infection after liver transplantation.
Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
[TBL] [Abstract][Full Text] [Related]
53. HLA and susceptibility to juvenile idiopathic arthritis: a study of affected sibpairs in an isolated Finnish population.
Säilä H; Pitkäniemi J; Tuomilehto J; Savolainen A; Alakulppi N; Tuomilehto-Wolf E; Leirisalo-Repo M; Aho K
J Rheumatol; 2004 Nov; 31(11):2281-5. PubMed ID: 15517645
[TBL] [Abstract][Full Text] [Related]
54. Donor HLA Class 1 Evolutionary Divergence Is a Major Predictor of Liver Allograft Rejection : A Retrospective Cohort Study.
Féray C; Taupin JL; Sebagh M; Allain V; Demir Z; Allard MA; Desterke C; Coilly A; Saliba F; Vibert E; Azoulay D; Guettier C; Chatton A; Debray D; Caillat-Zucman S; Samuel D
Ann Intern Med; 2021 Oct; 174(10):1385-1394. PubMed ID: 34424731
[TBL] [Abstract][Full Text] [Related]
55. Human leukocyte antigen class II associations with hepatitis C virus clearance and virus-specific CD4 T cell response among Caucasians and African Americans.
Harris RA; Sugimoto K; Kaplan DE; Ikeda F; Kamoun M; Chang KM
Hepatology; 2008 Jul; 48(1):70-9. PubMed ID: 18537178
[TBL] [Abstract][Full Text] [Related]
56. Sensitivity to bee venom antigen phospholipase A2: association with specific HLA class I and class II alleles and haplotypes in beekeepers and allergic patients.
Sánchez-Velasco P; Antón E; Muñoz D; Martínez-Quesada J; Ruíz de Alegría C; López-Hoyos M; García-Martín A; Jiménez I; Alonso ST; Duque S; Suárez A; Jerez J; Leyva-Cobián F
Hum Immunol; 2005 Jul; 66(7):818-25. PubMed ID: 16112029
[TBL] [Abstract][Full Text] [Related]
57. Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study.
Heward JM; Allahabadia A; Daykin J; Carr-Smith J; Daly A; Armitage M; Dodson PM; Sheppard MC; Barnett AH; Franklyn JA; Gough SC
J Clin Endocrinol Metab; 1998 Oct; 83(10):3394-7. PubMed ID: 9768636
[TBL] [Abstract][Full Text] [Related]
58. Development of donor-specific microchimerism in liver transplant recipient with HLA-DRB1 and -DQB1 mismatch related to rejection episodes.
Araújo MB; Leonardi LS; Boin IF; Leonardi MI; Magna LA; Donadi EA; Kraemer MH
Transplant Proc; 2004 May; 36(4):953-5. PubMed ID: 15194331
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of a histocompatibility antigen related to hepatitis B virus in patients with hepatocellular carcinoma in the western Brazilian Amazon.
Chalub SR; da Silva RM; da Silva AP; de Aquino PF; Sadahiro A; Kalil AN
Genet Mol Res; 2013 Apr; 12(2):1336-46. PubMed ID: 23661457
[TBL] [Abstract][Full Text] [Related]
60. Circulating anti-HLA antibodies in patients with chronic hepatitis C: relation to disease activity.
El Aggan HA; Sidkey F; El Gezery DA; Ghoneim E
Egypt J Immunol; 2004; 11(2):71-9. PubMed ID: 16734119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
